<?xml version="1.0" encoding="UTF-8"?>
<p id="p0065">The specific focus of COVID-19 studies has varied across different regions worldwide. China has mainly focused on the epidemiology of COVID-19. Patients in the early outbreak provided large samples of clinical characteristics and predictive spread of COVID-19. Research institutions on the Chinese mainland, such as Tongji Hospital, conducted numerous studies on the clinical characteristics and biochemical markers of COVID-19.
 <xref rid="bib6" ref-type="bibr">
  <sup>6</sup>
 </xref> A research foundation in Hong Kong, with 26 articles on SARS, rapidly initiated studies on the effective control of the spread of COVID-19. Research institutions in Hong Kong include universities (such as the University of Hong Kong, Hong Kong Polytechnic University) as well as hospitals (such as the Queen Mary Hospital), have focused on epidemiology as well as preventative and control measures for COVID-19.
 <xref rid="bib7" ref-type="bibr">
  <sup>7</sup>
 </xref>
 <sup>,</sup>
 <xref rid="bib8" ref-type="bibr">
  <sup>8</sup>
 </xref> The Government of Macau has placed greater emphasis on studies related to the prevention and control (one paper) and nursing care (one paper), and has taken early, proactive measures against transmission of COVID-19. Furthermore, studies performed by hospitals, in Taiwan (nine papers) (such as the National Taiwan University College of Medicine and regional general hospitals), have mainly focused on routes of transmission and clinical characteristics of COVID-19.
 <xref rid="bib9" ref-type="bibr">
  <sup>9</sup>
 </xref>
</p>
